Grandfield & Dodd LLC reduced its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 3.9% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 20,135 shares of the company’s stock after selling 822 shares during the period. Grandfield & Dodd LLC’s holdings in Colgate-Palmolive were worth $1,830,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in CL. Westside Investment Management Inc. boosted its holdings in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares during the period. Saudi Central Bank purchased a new stake in Colgate-Palmolive in the 1st quarter valued at $29,000. Ransom Advisory Ltd acquired a new stake in Colgate-Palmolive during the 1st quarter worth $33,000. Y.D. More Investments Ltd purchased a new position in Colgate-Palmolive during the 1st quarter worth $37,000. Finally, N.E.W. Advisory Services LLC acquired a new position in Colgate-Palmolive in the first quarter valued at $45,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on CL. Citigroup decreased their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Raymond James Financial lowered their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Evercore ISI reduced their target price on Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a report on Monday, November 3rd. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating on the stock in a research report on Monday, November 3rd. Finally, UBS Group reduced their price target on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. Nine equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $89.87.
Colgate-Palmolive Stock Up 0.2%
Shares of NYSE CL opened at $78.71 on Friday. The firm’s 50-day moving average is $79.32 and its two-hundred day moving average is $85.35. The company has a market capitalization of $63.45 billion, a PE ratio of 22.11, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.17 billion. During the same period last year, the company posted $0.91 EPS. The company’s revenue was up 1.9% on a year-over-year basis. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- What is a Low P/E Ratio and What Does it Tell Investors?
- Tesla Has Been Trapped in a 10% Range for Months—What’s Going On?
- How to invest in marijuana stocks in 7 steps
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- Insider Buying Explained: What Investors Need to Know
- Ondas Holdings Signals a Rebound as Drone Demand Soars
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
